In addition, we observed that CXB inhibited OSCC cell proliferation in 24 h of treatment assessed by PCNA immunoblotting and Ki-67 (green fluorescence) ICC-IF assays (Fig. 1B and C). The gene discussed is PCNA; the disease is intrahepatic cholangiocarcinoma.